View Single Post
Old 05-23-2016, 12:37 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,103
DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breas

The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.

More...
News is offline   Reply With Quote